![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Tasmanian Alkaloids Pty Ltd Westbury Au, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Codeine phosphate hemihydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1995-024 - Rev 04
This Chemical Type CEP, issued on August 22, 2006, remains in force until June 27, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 74 associated with this CEP further emphasizes